350 related articles for article (PubMed ID: 8064223)
1. Lipopolysaccharide (LPS)-binding protein is carried on lipoproteins and acts as a cofactor in the neutralization of LPS.
Wurfel MM; Kunitake ST; Lichenstein H; Kane JP; Wright SD
J Exp Med; 1994 Sep; 180(3):1025-35. PubMed ID: 8064223
[TBL] [Abstract][Full Text] [Related]
2. Lipopolysaccharide (LPS) binding protein catalyzes binding of LPS to lipoproteins.
Wurfel MM; Wright SD
Prog Clin Biol Res; 1995; 392():287-95. PubMed ID: 8524933
[TBL] [Abstract][Full Text] [Related]
3. Soluble CD14 acts as a shuttle in the neutralization of lipopolysaccharide (LPS) by LPS-binding protein and reconstituted high density lipoprotein.
Wurfel MM; Hailman E; Wright SD
J Exp Med; 1995 May; 181(5):1743-54. PubMed ID: 7536794
[TBL] [Abstract][Full Text] [Related]
4. Acute-phase concentrations of lipopolysaccharide (LPS)-binding protein inhibit innate immune cell activation by different LPS chemotypes via different mechanisms.
Hamann L; Alexander C; Stamme C; Zähringer U; Schumann RR
Infect Immun; 2005 Jan; 73(1):193-200. PubMed ID: 15618154
[TBL] [Abstract][Full Text] [Related]
5. Lipopolysaccharide is transferred from high-density to low-density lipoproteins by lipopolysaccharide-binding protein and phospholipid transfer protein.
Levels JH; Marquart JA; Abraham PR; van den Ende AE; Molhuizen HO; van Deventer SJ; Meijers JC
Infect Immun; 2005 Apr; 73(4):2321-6. PubMed ID: 15784577
[TBL] [Abstract][Full Text] [Related]
6. Structural determinants for the interaction of lipopolysaccharide binding protein with purified high density lipoproteins: role of apolipoprotein A-I.
Massamiri T; Tobias PS; Curtiss LK
J Lipid Res; 1997 Mar; 38(3):516-25. PubMed ID: 9101432
[TBL] [Abstract][Full Text] [Related]
7. Lipopolysaccharide-binding protein and phospholipid transfer protein release lipopolysaccharides from gram-negative bacterial membranes.
Vesy CJ; Kitchens RL; Wolfbauer G; Albers JJ; Munford RS
Infect Immun; 2000 May; 68(5):2410-7. PubMed ID: 10768924
[TBL] [Abstract][Full Text] [Related]
8. Priming of polymorphonuclear granulocytes by lipopolysaccharides and its complexes with lipopolysaccharide binding protein and high density lipoprotein.
Vosbeck K; Tobias P; Mueller H; Allen RA; Arfors KE; Ulevitch RJ; Sklar LA
J Leukoc Biol; 1990 Feb; 47(2):97-104. PubMed ID: 2154525
[TBL] [Abstract][Full Text] [Related]
9. Lipopolysaccharide binding protein and soluble CD14 catalyze exchange of phospholipids.
Yu B; Hailman E; Wright SD
J Clin Invest; 1997 Jan; 99(2):315-24. PubMed ID: 9006000
[TBL] [Abstract][Full Text] [Related]
10. Native high-density lipoprotein augments monocyte responses to lipopolysaccharide (LPS) by suppressing the inhibitory activity of LPS-binding protein.
Thompson PA; Kitchens RL
J Immunol; 2006 Oct; 177(7):4880-7. PubMed ID: 16982930
[TBL] [Abstract][Full Text] [Related]
11. Impact of sepsis-induced changes in plasma on LPS interactions with monocytes and plasma lipoproteins: roles of soluble CD14, LBP, and acute phase lipoproteins.
Kitchens RL; Thompson PA
J Endotoxin Res; 2003; 9(2):113-8. PubMed ID: 12803885
[TBL] [Abstract][Full Text] [Related]
12. Neutralization and transfer of lipopolysaccharide by phospholipid transfer protein.
Hailman E; Albers JJ; Wolfbauer G; Tu AY; Wright SD
J Biol Chem; 1996 May; 271(21):12172-8. PubMed ID: 8647810
[TBL] [Abstract][Full Text] [Related]
13. Lipopolysaccharide-binding protein and soluble CD14 transfer lipopolysaccharide to phospholipid bilayers: preferential interaction with particular classes of lipid.
Wurfel MM; Wright SD
J Immunol; 1997 Apr; 158(8):3925-34. PubMed ID: 9103463
[TBL] [Abstract][Full Text] [Related]
14. Lipopolysaccharide (LPS)-binding protein mediates LPS detoxification by chylomicrons.
Vreugdenhil AC; Rousseau CH; Hartung T; Greve JW; van 't Veer C; Buurman WA
J Immunol; 2003 Feb; 170(3):1399-405. PubMed ID: 12538700
[TBL] [Abstract][Full Text] [Related]
15. Plasma lipopolysaccharide-binding protein is found associated with a particle containing apolipoprotein A-I, phospholipid, and factor H-related proteins.
Park CT; Wright SD
J Biol Chem; 1996 Jul; 271(30):18054-60. PubMed ID: 8663389
[TBL] [Abstract][Full Text] [Related]
16. LPS-binding protein circulates in association with apoB-containing lipoproteins and enhances endotoxin-LDL/VLDL interaction.
Vreugdenhil AC; Snoek AM; van 't Veer C; Greve JW; Buurman WA
J Clin Invest; 2001 Jan; 107(2):225-34. PubMed ID: 11160139
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein A-II augments monocyte responses to LPS by suppressing the inhibitory activity of LPS-binding protein.
Thompson PA; Berbée JF; Rensen PC; Kitchens RL
Innate Immun; 2008 Dec; 14(6):365-74. PubMed ID: 19039060
[TBL] [Abstract][Full Text] [Related]
18. Fibrinogen is a component of a novel lipoprotein particle: factor H-related protein (FHRP)-associated lipoprotein particle (FALP).
Park CT; Wright SD
Blood; 2000 Jan; 95(1):198-204. PubMed ID: 10607703
[TBL] [Abstract][Full Text] [Related]
19. LPS-dependent interaction of Mac-2-binding protein with immobilized CD14.
Yu B; Wright SD
J Inflamm; 1995; 45(2):115-25. PubMed ID: 7583357
[TBL] [Abstract][Full Text] [Related]
20. Plasma lipoproteins promote the release of bacterial lipopolysaccharide from the monocyte cell surface.
Kitchens RL; Wolfbauer G; Albers JJ; Munford RS
J Biol Chem; 1999 Nov; 274(48):34116-22. PubMed ID: 10567381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
